Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis

Figure 2

Serum levels of sCD40L and MMP-9 in follow up of VL treatment and of endemic control subjects. (A) Compares sera levels of sCD40L and (B) MMP-9 in VL patients before (D0) and during treatment follow-up (D15, D30, D45, D60, D180) as measured by Luminex assay. *Mann–Whitney test and ** Wilcoxon signed rank test.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us